Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1101.

Lin28 enhances tissue repair by reprogramming cellular metabolism.

Cell.
Shyh-Chang N, Zhu H, Yvanka de Soysa T, Shinoda G, Seligson MT, Tsanov KM, Nguyen L, Asara JM, Cantley LC, Daley GQ.
| Nov 07, 2013
1102.

The quest to overcome resistance to EGFR-targeted therapies in cancer.

Nat. Med.
Chong CR, Jänne PA.
| 11 07, 2013
1103.

Development. A stem cell perspective on cellular engineering.

Science.
Doulatov S, Daley GQ.
| Nov 08, 2013
1105.

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Nat. Genet.
Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M.
| 11 03, 2013
1106.

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.

Nature.
Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, Narayan R, Flaherty KT, Wargo JA, Root DE, Garraway LA.
| Dec 05, 2013
1107.

Cancer-drug discovery and cardiovascular surveillance.

N. Engl. J. Med.
Groarke JD, Cheng S, Moslehi J.
| Nov 07, 2013
1108.

Linking the SWI/SNF complex to prostate cancer.

Nat. Genet.
Lee RS, Roberts CW.
| 10 30, 2013
1109.

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.

Nat. Med.
Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D, Mahale S, Davies KD, Aisner DL, Pilling AB, Berge EM, Kim J, Sasaki H, Park S, Kryukov G, Garraway LA, Hammerman PS, Haas J, Andrews SW, Lipson D, Stephens PJ, Miller VA, Varella-Garcia M, Jänne PA, Doebele RC.
| 10 27, 2013
1110.

Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop.

Nat Commun.
Sethi DK, Gordo S, Schubert DA, Wucherpfennig KW.
| 03 02, 2013
1111.

Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway.

Cell Metab.
Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, Lin JD, Greenberg ME, Spiegelman BM.
| Nov 05, 2013
1112.

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J.
| Jan 04, 2014
1113.

Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.

Cell Stem Cell.
Doulatov S, Vo LT, Chou SS, Kim PG, Arora N, Li H, Hadland BK, Bernstein ID, Collins JJ, Zon LI, Daley GQ.
| Oct 03, 2013
1114.

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.

Proc. Natl. Acad. Sci. U.S.A.
Johnson N, Johnson SF, Yao W, Li YC, Choi YE, Bernhardy AJ, Wang Y, Capelletti M, Sarosiek KA, Moreau LA, Chowdhury D, Wickramanayake A, Harrell MI, Liu JF, D'Andrea AD, Miron A, Swisher EM, Shapiro GI.
| Oct 15, 2013
1115.

Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.

Nat. Med.
Filbin MG, Dabral SK, Pazyra-Murphy MF, Ramkissoon S, Kung AL, Pak E, Chung J, Theisen MA, Sun Y, Franchetti Y, Sun Y, Shulman DS, Redjal N, Tabak B, Beroukhim R, Wang Q, Zhao J, Dorsch M, Buonamici S, Ligon KL, Kelleher JF, Segal RA.
| 09 29, 2013
1116.

Disruption of helix-capping residues 671 and 674 reveals a role in HIV-1 entry for a specialized hinge segment of the membrane proximal external region of gp41.

J. Mol. Biol.
Sun ZY, Cheng Y, Kim M, Song L, Choi J, Kudahl UJ, Brusic V, Chowdhury B, Yu L, Seaman MS, Bellot G, Shih WM, Wagner G, Reinherz EL.
| Mar 06, 2014
1117.

BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.

Mol. Cell.
Sarosiek KA, Chi X, Bachman JA, Sims JJ, Montero J, Patel L, Flanagan A, Andrews DW, Sorger P, Letai A.
| Sep 26, 2013
1118.

Pan-cancer patterns of somatic copy number alteration.

Nat. Genet.
Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhsng CZ, Wala J, Mermel CH, Sougnez C, Gabriel SB, Hernandez B, Shen H, Laird PW, Getz G, Meyerson M, Beroukhim R.
| 9 28, 2013
1119.

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

N. Engl. J. Med.
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H, Boeckh M, Marty F.
| Sep 26, 2013
1120.

Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.

J. Biol. Chem.
Kim M, Song L, Moon J, Sun ZY, Bershteyn A, Hanson M, Cain D, Goka S, Kelsoe G, Wagner G, Irvine D, Reinherz EL.
| Nov 01, 2013

Search